<DOC>
	<DOCNO>NCT00686335</DOCNO>
	<brief_summary>The purpose study evaluate subject suffer nocturnal asthma , efficacy safety modify release Prednisone sign symptom .</brief_summary>
	<brief_title>A New Modified-release Tablet Formulation Prednisone ( LodotraÂ® ) Patients With Nocturnal Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>The subject must able understand term write informed consent form , must provide dated signed form start study procedure At least 18 year old Patient diagnosis asthma date back 6 month time inclusion Asthma necessitate continuous treatment oral corticoid A minimum 3 nocturnal awakening due asthma last screening week Stable dose oral glucocorticoid least 4 week prior inclusion study No change asthma medication last 4 week prior V0 Nonsmoker exsmoker ( stop smoke one year previously smoke history le 10 pack year ) Female patient childbearing potential must use medically accept contraceptive regimen Able perform require study procedure include handle medication container diary Poorly control asthma , define meeting least one follow within 4 week prior Visit V0 : hospital admission asthma ( include treatment emergency room ) , low airway infection , Diagnosis chronic obstructive pulmonary disease relevant lung disease ( e.g . history bronchiectasis , cystic fibrosis , bronchiolitis , lung resection , lung cancer , active tuberculosis , interstitial lung disease ) Clinically significant abnormality hematological biochemical constant Pregnancy breastfeed Participation another clinical study within 30 day precede Visit V0 , Reentry patient previously enrol trial , Suspected inability unwillingness comply study procedure Alcohol drug abuse Need take nonauthorised concomitant treatment ( cf . list medicament authorise study ) course study Other disease require treatment corticosteroid Subject investigator subinvestigator , research assistant , pharmacist , study coordinator , staff relative thereof directly involve conduct protocol Patient hospitalisation schedule study period Any uncontrolled concomitant disease require clinical evaluation ( e.g . uncontrolled diabetes , uncontrolled hypertension , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>asthma</keyword>
	<keyword>nocturnal asthma</keyword>
	<keyword>glucocorticoid dependent persistent asthma</keyword>
	<keyword>sign symptom</keyword>
	<keyword>lung function</keyword>
	<keyword>prednisone</keyword>
</DOC>